Understanding the biological processes involved in cancer is crucial for developing effective treatments. Targeted therapies are designed to interfere with specific molecules involved in cancer growth and progression. For example, HER2 inhibitors target the HER2 protein in certain breast cancers, while PARP inhibitors are used for cancers with defects in DNA repair mechanisms.
Additionally, immunotherapy has emerged as a powerful treatment modality. By harnessing the body's immune system to recognize and destroy cancer cells, therapies like checkpoint inhibitors can provide durable responses in some patients.
